Ovion is made for a bigger screen here.
On a phone, use the Ovion Android app for the best experience.
Your alerts are unavailable right now (Not part of the demo)
Your notes are unavailable right now (Mira and AI features are off in the demo)
Shared as research context. It doesn't change any score or place trades.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.
Nothing scheduled in the next 30 days.
| Reported | EPS | Revenue |
|---|---|---|
| Sep 30, 2026 Beat | $-0.03 est. $-0.10 | $72.86M no estimate |
| Jun 30, 2026 Beat | $-0.07 est. $-0.13 | $64.08M no estimate |
| Mar 31, 2026 Beat | $-0.16 est. $-0.17 | $52.59M no estimate |
| Dec 31, 2025 Beat | $-0.12 est. $-0.16 | $49.13M no estimate |
Slipped under its 50-day average; still above its 200-day. The 200-day line is rising.
Options imply ±18.0% by Dec 18